Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 7651-7700 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05474651
Influencing Factors and Trigger Mechanism of Relapse in Expectant Fathers Who Quit Smoking
N/A
Active, not recruiting
294 participants
Started: Nov 23, 2022 · Completed: Apr 30, 2024
1 condition
1 sponsor
1 location
NCT05331183
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del
PHASE3
Active, not recruiting
297 participants
Started: Nov 23, 2022 · Completed: Apr 6, 2027
1 condition
1 sponsor
81 locations
NCT05517421
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
PHASE3
Active, not recruiting
100 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
93 locations
NCT05719116
A Combined Aerobic and Resistance Training Program for Adults With Psychotic Disorders
NA
Active, not recruiting
40 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT05779592
A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma
N/A
Active, not recruiting
400 participants
Started: Nov 23, 2022 · Completed: Sep 30, 2027
1 condition
2 sponsors
1 location
NCT05364762
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
PHASE2
Active, not recruiting
20 participants
Started: Nov 23, 2022 · Completed: May 22, 2026
7 conditions
2 sponsors
1 location
NCT05374603
Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC
PHASE2
Active, not recruiting
47 participants
Started: Nov 23, 2022 · Completed: Aug 30, 2025
1 condition
1 sponsor
16 locations
NCT05663892
Drug-Drug Interaction Study in Trans Women Living With HIV
PHASE4
Active, not recruiting
45 participants
Started: Nov 23, 2022 · Completed: Jan 31, 2025
2 conditions
1 sponsor
1 location
NCT05566925
Patients' Perceptions of Assessment and Treatment of Knee Osteoarthritis in Primary Care
N/A
Active, not recruiting
15 participants
Started: Nov 22, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
2 locations
NCT05838417
Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study
NA
Active, not recruiting
700 participants
Started: Nov 22, 2022 · Completed: Apr 1, 2026
1 condition
2 sponsors
2 locations
NCT05748327
Trial With Two New Tooth-colored Restorative Materials in Class I/II Cavities
NA
Active, not recruiting
58 participants
Started: Nov 22, 2022 · Completed: Apr 1, 2028
2 conditions
2 sponsors
1 location
NCT05272878
Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.
PHASE3
Active, not recruiting
508 participants
Started: Nov 22, 2022 · Completed: Jun 27, 2026
1 condition
1 sponsor
1 location
NCT05628883
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
PHASE1
Active, not recruiting
17 participants
Started: Nov 22, 2022 · Completed: Dec 31, 2026
10 conditions
2 sponsors
1 location
NCT05617508
N-DOSE AD: a Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's Disease
PHASE2
Active, not recruiting
80 participants
Started: Nov 22, 2022 · Completed: Oct 31, 2025
2 conditions
2 sponsors
2 locations
NCT07082257
Precision Performance Status Compared With ECOG Performance Status
N/A
Active, not recruiting
41 participants
Started: Nov 22, 2022 · Completed: May 28, 2026
2 conditions
2 sponsors
2 locations
NCT05602493
A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction
PHASE3
Active, not recruiting
60 participants
Started: Nov 22, 2022 · Completed: Oct 20, 2024
1 condition
1 sponsor
1 location
NCT05488873
A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy
PHASE2
Active, not recruiting
60 participants
Started: Nov 22, 2022 · Completed: May 30, 2026
1 condition
1 sponsor
1 location
NCT05424484
Mesh Augmented Reinforcement of Abdominal Wall Suture Line to Limit the Rate of Incisional Hernia Occurrence
NA
Active, not recruiting
123 participants
Started: Nov 22, 2022 · Completed: Sep 30, 2028
3 conditions
1 sponsor
13 locations
NCT05646589
A Person-centred Care Transition Support for People With Stroke/TIA
NA
Active, not recruiting
168 participants
Started: Nov 21, 2022 · Completed: Oct 31, 2025
2 conditions
2 sponsors
3 locations
NCT05241860
Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)
PHASE2
Active, not recruiting
79 participants
Started: Nov 21, 2022 · Completed: Sep 1, 2033
5 conditions
2 sponsors
326 locations
NCT05611671
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
PHASE2
Active, not recruiting
282 participants
Started: Nov 21, 2022 · Completed: Aug 31, 2026
2 conditions
1 sponsor
102 locations
NCT05456191
A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)
PHASE3
Active, not recruiting
568 participants
Started: Nov 21, 2022 · Completed: Jul 7, 2031
1 condition
1 sponsor
120 locations
NCT05868291
Daylight-controlled Lighting Adjusted for Geographical Orientation : Effects on Recovery, Energy Consumption and User Satisfaction
N/A
Active, not recruiting
900 participants
Started: Nov 21, 2022 · Completed: Apr 30, 2026
1 condition
2 sponsors
2 locations
NCT05394116
A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)
PHASE3
Active, not recruiting
63 participants
Started: Nov 21, 2022 · Completed: Feb 27, 2029
1 condition
1 sponsor
22 locations
NCT05570617
Transition to Adulthood Through Coaching and Empowerment
NA
Active, not recruiting
106 participants
Started: Nov 21, 2022 · Completed: Aug 31, 2025
2 conditions
1 sponsor
1 location
NCT05634161
Usability of Cognitive Improvement Software in Cognitively Impaired Patients: Pilot Study
N/A
Active, not recruiting
30 participants
Started: Nov 21, 2022 · Completed: Mar 31, 2024
1 condition
2 sponsors
1 location
NCT05500976
Metabolomics Initiative: Mediterranean-amplified vs Habitual Western Diet on Food Signatures, Health, and Microbiome
NA
Active, not recruiting
22 participants
Started: Nov 21, 2022 · Completed: Mar 31, 2025
1 condition
4 sponsors
1 location
NCT05436535
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
PHASE4
Active, not recruiting
433 participants
Started: Nov 21, 2022 · Completed: Oct 30, 2025
1 condition
1 sponsor
10 locations
NCT05556096
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
PHASE3
Active, not recruiting
260 participants
Started: Nov 21, 2022 · Completed: Aug 31, 2027
1 condition
1 sponsor
132 locations
NCT05568095
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
PHASE3
Active, not recruiting
1,040 participants
Started: Nov 21, 2022 · Completed: Feb 28, 2027
1 condition
3 sponsors
210 locations
NCT05381649
Empathy Anomalies in Emotionally Unstable (Borderline) Personality Disorder
N/A
Active, not recruiting
30 participants
Started: Nov 20, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05613283
Primary Cervical Cancer Screening by Self-sampling HPV Test
N/A
Active, not recruiting
17,875 participants
Started: Nov 19, 2022 · Completed: Aug 31, 2027
17 conditions
3 sponsors
6 locations
NCT05550740
Repeated Low-Level Red-Light Therapy for Shortening Axial Length
NA
Active, not recruiting
30 participants
Started: Nov 19, 2022 · Completed: Mar 23, 2026
3 conditions
1 sponsor
1 location
NCT05630950
LDCT-SC-FI Low-dose CT Screening for Lung Cancer
NA
Active, not recruiting
200 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
2 locations
NCT04756843
Early Orthodontic Treatment of Dental Crowding
NA
Active, not recruiting
60 participants
Started: Nov 18, 2022 · Completed: Jan 31, 2030
1 condition
2 sponsors
1 location
NCT05641519
Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County
NA
Active, not recruiting
483 participants
Started: Nov 18, 2022 · Completed: Jul 31, 2026
1 condition
7 sponsors
1 location
NCT05510115
Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
PHASE2
Active, not recruiting
50 participants
Started: Nov 18, 2022 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT06137820
CETI-ANKLE: Cetilar®️ in Patients With Ankle Injury or Chronic Trauma to the Ankle
NA
Active, not recruiting
80 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2023
1 condition
2 sponsors
3 locations
NCT05468489
To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
PHASE3
Active, not recruiting
200 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
67 locations
NCT06735989
Moral Reasoning Intervention on Moral Justification Abilities
NA
Active, not recruiting
150 participants
Started: Nov 18, 2022 · Completed: Feb 28, 2025
4 conditions
2 sponsors
1 location
NCT05614063
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
PHASE3
Active, not recruiting
360 participants
Started: Nov 18, 2022 · Completed: Feb 28, 2026
1 condition
2 sponsors
127 locations
NCT05495464
"A Pilot Window-3 Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma"
EARLY_PHASE1
Active, not recruiting
22 participants
Started: Nov 18, 2022 · Completed: Mar 31, 2027
2 conditions
3 sponsors
1 location
NCT05731440
Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease
N/A
Active, not recruiting
60 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05286801
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
PHASE1/PHASE2
Active, not recruiting
86 participants
Started: Nov 17, 2022 · Completed: Mar 31, 2030
18 conditions
1 sponsor
40 locations
NCT05953883
Proteogenomic Signatures Analysis In Ovarian Cancer
NA
Active, not recruiting
24 participants
Started: Nov 17, 2022 · Completed: Mar 17, 2025
1 condition
1 sponsor
1 location
NCT05455658
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
PHASE2
Active, not recruiting
33 participants
Started: Nov 17, 2022 · Completed: Jul 16, 2028
17 conditions
3 sponsors
3 locations
NCT05283980
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
PHASE2/PHASE3
Active, not recruiting
62 participants
Started: Nov 17, 2022 · Completed: Mar 31, 2025
7 conditions
1 sponsor
1 location
NCT05525585
Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants
NA
Active, not recruiting
80 participants
Started: Nov 17, 2022 · Completed: Oct 31, 2025
3 conditions
2 sponsors
1 location
NCT05486585
i-CBT Functional Gastrointestinal Disorders in Youth: the Impact of Negative Illness Understanding and Parental Illness Worries
NA
Active, not recruiting
60 participants
Started: Nov 17, 2022 · Completed: Jun 30, 2025
3 conditions
2 sponsors
1 location
NCT05394064
A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)
PHASE1/PHASE2
Active, not recruiting
16 participants
Started: Nov 17, 2022 · Completed: Mar 30, 2029
3 conditions
1 sponsor
2 locations
Previous
1
More pages
151
152
153
154
155
156
157
More pages
431
Next